Abstract
When India did well to contain the first wave of coronavirus disease 2019 (COVID-19) pandemic, none of us had an inkling of the magnitude that the second wave was going to take. One of the main reasons for the resurgence is several new mutants of this virus – the important ones for our country being UK Variant, Indian Double mutant, South African, and Brazil variants. Questions regarding their impact on virulence, pathogenicity, transmissibility, detection, clinical symptomatology, morbidity, mortality, potential curability, and possibly decreased therapeutic/ vaccine efficacy are being ascertained. We hereby summarize the importance of these variants with respect to Indian scenario, with emphasis on implications regarding COVID-19 diagnosis and efficacy of current vaccines.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Molecular and Immuno Oncology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
